Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer.
Postoperative delirium.
The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs.
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients.
Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients. Cancers (Basel). 2021 Jun 03; 13(11).
View in:
PubMed
authors with profiles
Ravi Salgia